# Immunome, Inc. (IMNM)

> Source: Nexqual · https://nexqual.com/IMNM · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Immunome, Inc. (IMNM), nexqual.com/IMNM" · informational, not investment advice.

**Price:** USD 17.4 (+1.16% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 17.2 · day 17.08–17.61 · 52w 14.64–30.06 · market cap $2.05B · NCM

## Key facts
- Analysts: Buy (mean 1.88 on a 1–5 scale) (16 analysts), mean target USD 35.2 (range 24–40).
- Total return with dividends: 1Y +5.5% vs S&P 500 +18.1%; 5Y -1.2% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD -0.59, revenue estimate $143K.

## Analysts
Consensus Buy (mean 1.88 on a 1–5 scale), 16 analysts; mean target USD 35.2 (low 24, high 40).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-01 | Stifel | Initiated | Hold | $24 |
| 2026-09-21 | Alliance Global Partners | Initiated | Buy | $32 |
| 2026-09-10 | HC Wainwright & Co. | Reiterated | Buy | $40 |
| 2026-08-12 | Truist Securities | Target raised | Buy | $37 → $38 |
| 2026-08-12 | Wedbush | Target raised | Outperform | $31 → $35 |
| 2026-07-21 | Wedbush | Reiterated | Outperform | $31 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | +5.5% | -1.2% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +5.5% | -0.2% |
| Volatility (annualized) | 61.1% | 94.8% |
| Max drawdown | -42.3% (Aug 2026→Oct 2026) | -90.6% (Oct 2021→Dec 2022) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/IMNM · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt